SCHEMBL25501771

SCHEMBL25501771

O=S(=O)(Nc1ccc(Cl)cc1Cl)N1CCCC(C(c2ccc(F)cc2)c2ccc(F)cc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
KMT2A Q03164 4/20 0.46
NPSR1 Q6W5P4 2/20 0.46
MEN1 O00255 2/20 0.46
NPY1R P25929 1/20 0.46
NPY2R P49146 1/20 0.46
HTT P42858 3/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
CNR1 P21554 7/20 0.39
CNR2 P34972 3/20 0.39
FKBP1A P62942 1/20 0.38
GLA P06280 1/20 0.38
TSHR P16473 2/20 0.36
KDM4E B2RXH2 1/20 0.36
SLC6A3 Q01959 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25502062 0.90 FKBP1A (0.43) MAPTKMT2ANPSR1MEN1NPY1R
SCHEMBL23848802 0.88 KMT2A (0.44) MAPTKMT2ANPSR1MEN1NPY1R
SCHEMBL23832794 0.85 FKBP1A (0.52) MAPTKMT2AMEN1HTTLMNA
SCHEMBL23832764 0.85 FKBP1A (0.52) MAPTKMT2AMEN1HTTLMNA
SCHEMBL25501762 0.84 KMT2A (0.52) MAPTKMT2AMEN1HTTLMNA
SCHEMBL23832777 0.82 POLB (0.47) MAPTKMT2AMEN1HTTLMNA
SCHEMBL25168240 0.82 POLB (0.47) MAPTKMT2AMEN1HTTLMNA
SCHEMBL23848269 0.81 KMT2A (0.58) MAPTKMT2AMEN1HTTLMNA
SCHEMBL25501803 0.81 MAPT (0.41) MAPTKMT2ANPSR1MEN1NPY1R
SCHEMBL23832804 0.78 KMT2A (0.51) MAPTKMT2AMEN1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF ATUX ISKAY LLC 2023-05-11 US disclosed
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF ATUX ISKAY LLC 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF MYC, MYCBP, FOXO1 MAPT 2576/4885KMT2A 742/4885NPSR1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.